shikonin

nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 ; Mus musculus







7 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33707115 Shikonin-mediated PD-L1 degradation suppresses immune evasion in pancreatic cancer by inhibiting NF-κB/STAT3 and NF-κB/CSN5 signaling pathways. 2021 Apr 5
2 32272431 Shikonin mitigates ovariectomy-induced bone loss and RANKL-induced osteoclastogenesis via TRAF6-mediated signaling pathways. 2020 Jun 2
3 32473224 Shikonin relieves osteoporosis of ovariectomized mice by inhibiting RANKL-induced NF-κB and NFAT pathways. 2020 Sep 1 2
4 32952636 Non-cytotoxic doses of shikonin inhibit lipopolysaccharide-induced TNF-α expression via activation of the AMP-activated protein kinase signaling pathway. 2020 Nov 1
5 24447680 Shikonin inhibits the lipopolysaccharide-induced release of HMGB1 in RAW264.7 cells via IFN and NF-κB signaling pathways. 2014 Mar 1
6 23201088 Shikonin ameliorates cerulein-induced acute pancreatitis in mice. 2013 Jan 30 1
7 20423347 Shikonin reduces oedema induced by phorbol ester by interfering with IkappaBalpha degradation thus inhibiting translocation of NF-kappaB to the nucleus. 2010 May 1